{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:12:03Z","timestamp":1791479523332,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.clinbiochem.2006.06.004","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T23:41:19Z","timestamp":1153870879000},"page":"961-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations"],"prefix":"10.1016","volume":"39","author":[{"given":"Cengiz","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tercan","family":"Us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timu\u00e7in","family":"Ka\u015fifo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurdanur","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2006.06.004_bib1","series-title":"Kelley's Textbook of Rheumatology","first-page":"301","article-title":"Rheumatoid factor","author":"Tighe","year":"2005"},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenaar","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0","article-title":"Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis","volume":"44","author":"Reparon-Schuijt","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005792-198611000-00002","article-title":"Rheumatoid vasculitis. Survival and associated risk factors","volume":"65","author":"Vollertsen Conn","year":"1986","journal-title":"Medicine"},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ard.48.1.7","article-title":"Factors predicting the prognosis in rheumatoid arthritis: an eight year prospective study","volume":"48","author":"Erhardt","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib6","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1172\/JCI115814","article-title":"Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis","volume":"89","author":"Weyand","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/030097400447552","article-title":"Predictors of extra-articular manifestations in rheumatoid arthritis","volume":"29","author":"Turesson","year":"2000","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/39.10.1082","article-title":"Association of rheumatoid factors and anti-flaggrin antibodies with severity of erosions in rheumatoid arthritis","volume":"39","author":"Bas","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib9","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.20316","article-title":"Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/ard.62.9.897","article-title":"Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity","volume":"62","author":"Carmona","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-139-3-200308050-00021","article-title":"Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis","volume":"139","author":"Pinheiro","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","article-title":"How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis","volume":"46","author":"Visser","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2004.02.001","article-title":"Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients","volume":"72","author":"Zrour","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/PL00006853","article-title":"Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis","volume":"19","author":"Cimmino","year":"2000","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/art.20028","article-title":"Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib17","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7705\/biomedica.v24i2.1260","article-title":"Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB","volume":"24","author":"Correa","year":"2004","journal-title":"Biomedica"},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","article-title":"Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis","volume":"63","author":"Vallbracht","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","article-title":"Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis","volume":"47","author":"Bizzaro","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib22","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib23","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.20659","article-title":"Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody","volume":"50","author":"Mikuls","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014647","article-title":"Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNF-alpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement","volume":"63","author":"Alessandri","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/ard.2005.038851","article-title":"The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis","volume":"65","author":"Chen","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/ard.2004.023523","article-title":"Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis","volume":"64","author":"De Rycke","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00296-004-0571-9","article-title":"Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment","volume":"26","author":"Caramaschi","year":"2005","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/ard.2004.032136","article-title":"Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis","volume":"64","author":"Spadaro","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2006.06.004_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009748209098194","article-title":"Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study","volume":"11","author":"Jurik","year":"1982","journal-title":"Scand. J. Rheumatol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912006002165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912006002165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:24:16Z","timestamp":1757863456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912006002165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0009912006002165"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.06.004","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2006.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}